e-learning
resources
European Respiratory Review
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A critical analysis of survival in pulmonary arterial hypertension
Dermot S. O'Callaghan, Marc Humbert
Source:
Eur Respir Rev 2012 21: 218-222
Journal Issue:
September 2012 - 21 (125)
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dermot S. O'Callaghan, Marc Humbert. A critical analysis of survival in pulmonary arterial hypertension. Eur Respir Rev 2012 21: 218-222
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012
Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005
Predicting survival in pulmonary arterial hypertension in the UK},
Source: Eur Respir J 2012; 40: 604-611
Year: 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
A USA-based registry for pulmonary arterial hypertension: 1982 2006
Source: Eur Respir J 2007; 30: 1103-1110
Year: 2007
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003
Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011
The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy
Source: Eur Respir J 2001; 17: 653-659
Year: 2001
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020
Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH)
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept